Morningstar: Priced For Complete Growth Collapse

Morningstar delivered 10.8% revenue growth and 42.6% adjusted diluted EPS growth in Q1 2026, while its Credit business stood out as a key performer. Management also tripled share repurchases to $300 million and raised dividends, signaling confidence in the stock’s deep undervaluation. The article frames MORN as trading at roughly one-third of its 10-year average P/E despite solid operating execution.

Analysis

The market is still pricing MORN like a cyclical data utility, but the setup looks more like a quality compounder with underappreciated operating leverage. When a business can convert mid-single to low-double-digit top-line growth into much faster EPS growth, the key question is not whether the numbers are good — it is whether the street is anchoring on a stale margin framework. The multiple compression versus its own history suggests sentiment, not fundamentals, is the binding constraint.

The buyback step-up matters more than the headline size implies. At this valuation, repurchases become structurally more accretive than almost any internal capital deployment, and the signal effect can attract fundamental buyers who screen for high FCF yield plus management hostility to dilution. That can create a self-reinforcing rerating loop over the next 1-2 quarters if execution remains intact and repurchases absorb incremental supply.

The main risk is that the market is discounting a temporary credit-cycle peak in the business mix, especially if investors believe Credit strength is the part most exposed to normalization. If that segment slows while the rest of the portfolio merely stays solid, the stock can remain cheap longer than value investors expect. The reversal catalyst would be another quarter of broad-based growth plus continued aggressive capital returns, which would force consensus to move from "show me" to "re-rate it."

The contrarian view is that the opportunity is not in discovering hidden growth, but in recognizing that the downside is likely limited by capital returns while the upside is driven by multiple mean reversion. In other words, even modest disappointment may not break the thesis because management is effectively underwriting the stock with buybacks and dividends. That makes the risk/reward asymmetric over a 6-12 month horizon rather than a trading-day catalyst story.

Key Decisions for Investors

• Go long MORN on pullbacks over the next 1-4 weeks; target a 15-20% rerating over 6-12 months if the market revalues it toward even a partial P/E mean reversion.
• If already long, hold through the next earnings print and add on confirmation of continued buyback cadence; the incremental repurchase signal is a stronger catalyst than the dividend raise.
• Structure a call spread in MORN for a 3-6 month horizon to express upside from multiple expansion while limiting capital at risk if credit-related sentiment cools.
• Use MORN as a pair long against a lower-quality information-services or data-subscription peer with weaker capital returns; the cleaner balance-sheet/return-of-capital story should outperform if the factor rotates toward shareholder yield.
• Set a risk stop if management slows repurchases materially or if revenue growth decelerates into the high-single digits for two consecutive quarters; that would undermine the rerating case.